文献速递肝病消化道肿瘤与早癌

家族性与散发性肝脏肿瘤中的胚系与体细胞DICER1突变

Germline and somatic DICER1 mutations in familial and sporadic liver tumors.
PubMed 文献 · J Hepatol · 2016-12-22

研究报道一个家族中两名成员携带新型胚系DICER1突变并反复发生高分化肝细胞肿瘤,肿瘤均显示Wnt/β-catenin通路激活及谷氨酰胺合成酶强弥漫表达。在243例散发性肝肿瘤中检出6例体细胞DICER1突变,肝癌中DICER1突变与CTNNB1突变显著相关(p=0.03)。DICER1突变肿瘤成熟miRNA表达降低,let-7a和miR-365b下调与DICER1突变密切相关。

要点

  • 家族性病例携带新型胚系DICER1突变,肿瘤为肝细胞腺瘤和高分化癌。
  • 243例散发性肝肿瘤中6例存在体细胞DICER1突变。
  • 肝癌中DICER1突变与CTNNB1突变显著相关(p=0.03)。

核心结论

  • DICER1突变在伴有β-catenin激活的特定亚型家族性和散发性肝细胞癌的肝癌发生中起作用。

研究设计与样本

  • 研究一个家族中两名反复发生高分化肝细胞肿瘤的个体,对其手术切除肿瘤的组织学切片进行复核。
  • 对两名患者循环淋巴细胞的体质DNA进行外显子测序。
  • 在243例肝肿瘤中分析体细胞DICER1突变的存在。
  • 对50例肝肿瘤进行微小RNA(miRNA)测序,以识别具有相似表达谱的肿瘤组和差异表达miRNA(DEM)。

主要发现

  • 病理学研究在两名患者中鉴定出肝细胞腺瘤和高分化癌。
  • 肿瘤显示Wnt/β-catenin通路激活,谷氨酰胺合成酶呈强而弥漫表达。
  • 非肿瘤肝组织显示异常肝脏分区,与既往在Dicer1敲除小鼠肝脏中的报道相似。
  • 在243例散发性肝肿瘤中筛查DICER1突变,鉴定出6例肿瘤存在体细胞DICER1突变。
  • 在肝细胞癌中,DICER1突变与CTNNB1突变显著相关(p=0.03)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Growing evidence suggests that genetic predisposition significantly increases the risk of hepatocellular carcinoma (HCC), independently from the presence of other risk factors. Here, we report a novel germline DICER1 mutation associated with familial recurrent liver tumors. We then aimed to investigate the contribution of constitutional and somatic DICER1 mutations on HCC occurrence. METHODS: We investigated two individuals of a single family that developed recurrent well-differentiated hepatocellular tumors over the years. Histological slides from surgically resected tumors were reviewed. Exome sequencing was performed on constitutional DNA from circulating lymphocytes in both patients. The presence of somatic DICER1 mutations was analyzed in 243 liver tumors. MicroRNA (miRNA) sequencing was performed in 50 liver tumors to identify groups of tumors with similar profiles and differentially expressed miRNAs (DEMs). RESULTS: A pathological study identified hepatocellular adenomas and well-differentiated carcinomas in both patients. Tumors exhibited Wnt/β-catenin pathway activation, with strong and diffuse glutamine synthetase expression. Interestingly, non-tumor liver tissues showed abnormal liver zonation as previously reported in Dicer1 knockout mouse livers. Screening for DICER1 mutations in 243 sporadic liver tumors identified six tumors with somatic DICER1 mutations. In HCCs, DICER1 mutations were significantly associated with CTNNB1 mutations (p=0.03). miRNA profiling identified a specific expression profile in DICER1-mutated tumors with a decreased expression of mature miRNAs compared to the other samples. Among the DEMs, downregulation of let-7a and miR-365b was closely related to DICER1 mutations. CONCLUSIONS: Our results highlight the role of DICER1 mutations in liver carcinogenesis in a specific subtype of familial and sporadic hepatocellular carcinomas associated with β-catenin activation. LAY SUMMARY: DICER1 germline mutations are known to predispose individuals to the development of malignant tumors, mainly pleuropulmonary blastoma and ovarian Sertoli-Leydig cell tumor. Here, we described familial HCC associated with a novel DICER1 germline mutation and altered liver zonation. Familial and sporadic HCCs carrying DICER1 mutations are associated with CTNNB1 mutation and characterized by a reduced expression of specific mature miRNAs.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Caruso S, Calderaro J, Letouzé E, et al. Germline and somatic DICER1 mutations in familial and sporadic liver tumors. J Hepatol. 2016. PMID: 28012864. doi:10.1016/j.jhep.2016.12.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。